Augmenting therapy of ovarian cancer efficacy by secreting IL-21 human umbilical cord blood stem cells in nude mice

Cell Transplantation

Volumn 20, Issue 5, 2011, Pages 669-680

  Hu, Weihua ^a   Wang, Jing ^a   Dou, Jun ^a   He, Xiangfeng ^a   Zhao, Fengshu ^a   Jiang, Cuilian ^a   Yu, Fangliu ^a   Hu, Kai ^a   Chu, Lili ^b   Li, Xiaoli ^a   Gu, Ning ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b CHILDREN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Gene therapy; Interleukin 21; Ovarian cancer; Umbilical cord blood stem cells (UCBSCs)

Indexed keywords

CD34 ANTIGEN; CD56 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 21; INTERLEUKIN 4; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GENE THERAPY; DRUG EFFICACY; HUMAN; HUMAN CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; TERATOMA; TUMOR VOLUME; TUMOR XENOGRAFT; UMBILICAL CORD BLOOD; UMBILICAL CORD BLOOD STEM CELL;

ANIMALS; ANTIGENS, CD34; FEMALE; FETAL BLOOD; GROWTH DIFFERENTIATION FACTOR 15; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-4; INTERLEUKINS; KILLER CELLS, NATURAL; MICE; MICE, NUDE; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; OVARIAN NEOPLASMS; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSPLANTATION, HETEROLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

MUS; MUS MUSCULUS;

EID: 79960003532     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X536509     Document Type: Article

References (39)

1. Alvarez-Mercado, A. I.; Garcia-Mediavilla, M. V.; Sanchez- Campos, S.; Abadia, F.; Saez-Lara, M. J.; Cabello- Donayre, M.; Gil, A.; Gonzalez-Gallego, J.; Fontana, L. Deleterious effect of human umbilical cord blood mono- nuclear cell transplantation on thioacetamide-induced chronic liver damage in rats. Cell Transplant. 18:1069-1079; 2009.
2. Attar, R.; Attar, E. Use of hematopoietic stem cells in obstetrics and gynecology. Transfus. Apher. Sci. 38:245-251; 2008.
3. Banerjee, S.; Nandyala, A.; Podili, R.; Katoch, V. M.; Murthy, K. J.; Hasnain, S. E. Mycobacterium tuberculosis (Mtb) isocitrate dehydrogenases show strong B cell response and distinguish vaccinated with controls from TB patients. Proc. Natl. Acad. Sci. USA 101:12652-12657; 2004.
4. Bauer, S.; Groh, V.; Wu, J.; Steinle, A.; Phillips, J. H.; Lanier, L. L.; Spies, T. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285:727-729; 1999.
5. Bilkenroth, U.; Taubert, H.; Riemann, D. Detection and enrichment of disseminated renal carcinoma cells from pe- ripheral blood by immunomagnetic cell separation. Int. J. Cancer 92:577-682; 2001.
6. Calzascia, T.; Pellegrini, M.; Hall, H.; Sabbagh, L.; Ono, N.; Elford, A. R.; Mak, T. W.; Ohashi, P. S. TNF- is critical for antitumor but not antiviral T cell immunity in mice. J. Clin. Invest. 117:3833-3845; 2007.
7. Chang, Y. S.; Oh, W.; Choi, S. J.; Sung, D. K.; Kim, S. Y.; Choi, E. Y.; Kang, S.; Jin, H. J.; Yang, Y. S.; Park, W. S. Human umbilical cord blood-derived mesenchymal stem cells attenuate hyperoxia-induced lung injury in neonatal rats. Cell Transplant. 18:869-886; 2009.
8. + cord blood cell-transplanted Rag2-/- gamma(c)-/- mice as a model for Epstein-Barr virus infec- tion. Am. J. Pathol. 173:1369-1378; 2008.
9. Dou, J.; Chen, G.; Wang, J.; Zhao, F.; Chen, J.; He, X. F.; Tang, Q.; Chu, L. Preliminary study on mouse interleukin 21 application in tumor gene therapy. Cell. Mol. Immunol. 1:388-396; 2004.
10. Dou, J.; Chu, L.; Zhao, F.; Tang, Q.; Zhang, A.; Zhang, L.; Wang, Y.; Li, Y.; Cao, M.; Gu, N. Study of immuno- therapy of murine myeloma by an IL-21-based tumor vac- cine in BALB/C mice. Cancer Biol. Ther. 6:1871-1879; 2007.
11. Dou, J.; Hong, X.; Zhao, F.; Wang, J.; Chen, J.; Chen, G. Investigation of GM-CSF immune accessory effects in tumor-bearing mice by direct gene immunization. Immu- nol. Invest. 35:227-237; 2006.
12. Dou, J.; Liu, P.; Wang, J.; Zhang, X. Effect of hepatitis C virus core shadow protein expressed in human hepatoma cell line on human gene expression profiles. J. Gastroent- erol. Hepatol. 21:1794-1800; 2006.
13. Dou, J.; Tang, Q.; Yu, F.; Yang, H.; Zhao, F.; Xu, W.; Wang, J.; Hu, W.; Hu, K.; Liou, C.; He, X. F.; Wang, Y. Investigation of immune effect based on BCG priming and Plasmid DNA expressing Ag85A&GM-CSF boosting in Balb/c mice model. Immunobiology 215:133-142; 2010.
14. Dou, J.; Wang, Y.; Wang, J.; Zhao, F.; Li, Y.; Cao, M.; Hu, W.; Hu, K.; He, X. F.; Chu, L.; Jiang, C.; Gu, N. Antitumor efficacy induced by human ovarian cancer cells secreting IL-21 alone or combination with GM-CSF cyto- kines in nude mice model. Immunobiology 214:483-492; 2009.
15. Ferrandina, G.; Martinelli, E.; Petrillo, M.; Prisco, M. G.; Zannoni, G.; Sioletic, S.; Scambia, G. CD133 antigen ex- pression in ovarian cancer. BMC Cancer 9:221; 2009.
16. Ganta, C.; Chiyo, D.; Ayuzawa, R.; Rachakatla, R.; Pyle, M.; Andrews, G.; Weiss, M.; Tamura, M.; Troyer, D. Rat umbilical cord stem cells completely abolish rat mammary carcinomas with no evidence of metastasis or recurrence 100 days post-tumor cell inoculation. Cancer Res. 69: 1815-1820; 2009.
17. + human umbilical cord blood cells generate multiple lymphohematopoietic lineages in NOD-scid IL2rgamma (null) mice. Exp. Biol. Med. 233:997-1012; 2008.
18. Hakkarainen, T.; Hemminki, A.; Pereboev, A. V.; Barker, S. D.; Asiedu, C. K.; Strong, T. V.; Kanerva, A.; Wahl- fors, J.; Curiel, D. T. CD40 is expressed on ovarian cancer cells and can be utilized for targeting adenoviruses. Clin. Cancer Res. 9:619-624; 2003.
19. + cells on transplanted malignancy in a mouse model of hepatic cancer. Cell Transplant. 17:969-975; 2008.
20. Kim, S. M.; Lim, J. Y.; Park, S. I.; Jeong, C. H.; Oh, J. H.; Jeong, M.; Oh, W.; Park, S. H.; Sung, Y. C.; Jeun, S. S. Gene therapy using TRAIL-secreting human umbili- cal cord blood-derived mesenchymal stem cells against in-tracranial glioma. Cancer Res. 68:9614-9623; 2008.
21. Kim-Schulze, S.; Kim, H. S.; Fan, Q.; Kim, D. W.; Kauf-man, H. L. Local IL-21 promotes the therapeutic activity of effector T cells by decreasing regulatory T cells within the tumor microenvironment. Mol. Ther. 17:380-388; 2009.
22. Kohli-Kumar, M.; Shahidi, N. T.; Broxmeyer, H. E.; Masterson, M.; Dalaat, C.; Sambrano, J.; Morris, C.; Auerbach, A. D.; Harris, R. E. Haemopoietic stem/progen- itor cell transplant in Fanconi anaemia using HLA-matched sibling umbilical cord blood cells. Br. J. Haema- tol. 85:419-422; 1993.
23. Kollet, O.; Spiegel, A.; Peled, A.; Petit, I.; Byk, T.; Hersh-koviz, R.; Guetta, E.; Barkai, G.; Nagler, A.; Lapidot, T. Rapid and efficient homing of human CD34(+)CD38(-/low) CXCR4(+) stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2m (null) mice. Blood 97:3283-3291; 2001.
24. Kristiansen, G.; Denkert, C.; Schlns, K.; Dahl, E.; Pilar-sky, C.; Hauptmann, S. CD24 is expressed in ovarian can- cer and is a new independent prognostic marker of patient survival. Am. J. Pathol. 161:1215-1221; 2002.
25. Lecoeur, H.; Février, M.; Garcia, S.; Riviére, Y.; Gougeon, M. L. A novel flow cytometric assay for quanti- tation and multiparametric characterization of cell-mediated cytotoxicity. J. Immunol. Methods 253:177-187; 2001.
26. Lin, H.; Cheung, S. W.; Nesin, M.; Cassileth, B. R.; Cunningham-Rundles, S. Enhancement of umbilical cord blood cell hematopoiesis by Maitake beta-glucan is medi- ated by granulocyte colony-stimulating factor production. Clin. Vaccine Immunol. 14:21-27; 2007.
27. Martinez-Jaramillo, G.; Flores-Guzman, P.; Montesino, J. J.; Quintana, S.; Bautista, J.; Sanchez-Valle, E.; Mayani, H. In vitro proliferation and expansion of hematopoietic progenitors present in mobilized peripheral blood from normal subjects and cancer patients. Stem Cells Dev. 13: 382-389; 2004.
28. Mimeault, M.; Hauke, R.; Batra, S. K. Stem cells: A revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies. Clin. Pharmacol. Ther. 82:252-264; 2007.
29. + stem cells from human cord blood. In Vivo 21:493-498; 2007.
30. Perez, S. A.; Mahaira, L. G.; Sotiropoulou, P. A.; Grit-zapis, A. D.; Iliopoulou, E. G.; Niarchos, D. K.; Cacoullos, N. T.; Kavalakis, Y. G.; Antsaklis, A. I.; Sotiriadou, N. N.; Baxevanis, C. N.; Papamichil, M. Effect of IL-21 on NK cells derived from different umbilical cord blood populations. Int. Immunol. 18:49-58; 2006.
31. Perillo, A.; Pierelli, L.; Scambia, G.; Leone, G.; Mancuso, S. The role of hematopoietic stem cells in the treatment of ovarian cancer. Panminerva Med. 44:197-204; 2002.
32. Quiros, R. M.; Valianou, M.; Kwon, Y.; Brown, K. M.; Godwin, A. K.; Cukierman, E. Ovarian normal and tumor- associated fibroblasts retain in vivo stromal characteristics in a 3-D matrix- dependent manner. Gynecol. Oncol. 110: 99-109; 2008.
33. Rachakatla, R. S.; Marini, F.; Weiss, M. L.; Tamura, M.; Troyer, D. Development of human umbilical cord matrix stem cell-based gene therapy for experimental lung tumors. Cancer Gene Ther. 14:828-835; 2007.
34. Rachakatla, R. S.; Pyle, M. M.; Ayuzawa, R.; Edwards, S. M.; Marini, F. C.; Weiss, M. L. Combination treatment of human umbilical cord matrix stem cell-based inter- feron-beta gene therapy and 5-fluorouracil significantly reduces growth of metastatic human breast cancer in SCID mouse lungs. Cancer Invest. 26:662-670; 2008.
35. + cytotoxic-T-lymphocyte re- sponse and viral clearance in mice with primary respiratory syncytial virus infection. J. Virol. 78:3014-3023; 2004.
36. Shu, S.; Cochran, A. J.; Huang, R. R.; Morton, D. L.; Maecker, H. T. Immune responses in the draining lymph nodes against cancer: Implications for immunotherapy. Cancer Metastasis Rev. 25:233-242; 2006.
37. Steiner, D.; Gelovani, J.; Savoldo, B.; Robinson, S. N.; Decker, W. K.; Brouard, N.; Najjar, A.; Xing, D.; Yang, H.; Li, S.; Marini, F.; Zweidler-McKay, P. A.; Bollard, C. M.; Shpall, E. J.; Dotti, G.; Simmons, P. J. Noninvasive bioluminescent imaging demonstrates long-term multilin- eage engraftment of ex vivo-expanded CD34-selected um- bilical cord blood cells. Stem Cells 27:1932-1940; 2009.
38. Wilk, E.; Kalippke, K.; Buyny, S.; Schmidt, R. E.; Jacobs, R. New aspects of NK cell subset identification and inference of NK cells' regulatory capacity by assessing functional and genomic profiles. Immunobiology 213:271-283; 2008.
39. Zhao, F.; Dou, J.; Wang, J.; Chu, L.; Tang, Q.; Wang, Y.; Li, Y.; Cao, M.; Hu, W.; Hu, K.; He, F. X.; Gu, N. Investigation on the anti-tumor efficacy by expression of GPI-anchored mIL-21 on the surface of B16F10 cells in C57BL/6 mice. Immunobiology 215:133-142; 2010.